[Strongyloidosis. Part IX. Treatment].
The treatment of chronic and massive (uncomplicated) and severe (complicated) disseminated strongyloidosis, was presented from the historical point of view. The sequence of achievements in regard of treatment of the gentian violet, dithiazine iodide, benzimidazoles (thiabendazole, mebendazole, albendazole, cambendazole), ivermectin and cyclosporin A, was described. The recommendations for treatment of strongyloidosis are also given.
Soroczan
Wiesław
W
Katedra i Zakład Biologii i Parazytologii, Akademia Medyczna, ul. Radziwiłłowska 11, 20-080 Lublin.
D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000923:Anticestodal Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use; D002159:Cambendazole / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy* / Q000276:immunology; D007559:Ivermectin / Q000627:therapeutic use; D008174:Lung Diseases, Parasitic / Q000188:drug therapy; D008463:Mebendazole / Q000627:therapeutic use; D017171:Strongyloides stercoralis / Q000187:drug effects*; D013322:Strongyloidiasis / Q000188:drug therapy* / Q000469:parasitology; D013827:Thiabendazole / Q000627:therapeutic use
D000923:Anticestodal Agents; D001562:Benzimidazoles; D002159:Cambendazole; D007559:Ivermectin; D008463:Mebendazole; D015766:Albendazole; D013827:Thiabendazole